Renaissance Technologies’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $31.9M | Buy |
576,735
+31,435
| +6% | +$1.5M | 0.05% | 472 |
|
|
2025
Q4 | $20.4M | Sell |
545,300
-9,900
| -2% | -$402K | 0.03% | 589 |
|
|
2025
Q3 | $22.5M | Sell |
555,200
-55,600
| -9% | -$1.84M | 0.03% | 672 |
|
|
2025
Q2 | $15.6M | Sell |
610,800
-94,500
| -13% | -$2.06M | 0.02% | 823 |
|
|
2025
Q1 | $15.1M | Buy |
705,300
+147,500
| +26% | +$3.3M | 0.02% | 796 |
|
|
2024
Q4 | $11.7M | Buy |
557,800
+10,600
| +2% | +$245K | 0.02% | 916 |
|
|
2024
Q3 | $12.3M | Buy |
547,200
+20,400
| +4% | +$394K | 0.02% | 934 |
|
|
2024
Q2 | $8.83M | Sell |
526,800
-200
| -0% | -$3.21K | 0.02% | 994 |
|
|
2024
Q1 | $6.81M | Sell |
527,000
-47,600
| -8% | -$571K | 0.01% | 1215 |
|
|
2023
Q4 | $6.65M | Buy |
574,600
+47,900
| +9% | +$541K | 0.01% | 1171 |
|
|
2023
Q3 | $6.73M | Buy |
526,700
+1,200
| +0.2% | +$17K | 0.01% | 1137 |
|
|
2023
Q2 | $7.2M | Buy |
525,500
+1,500
| +0.3% | +$21.5K | 0.01% | 1199 |
|
|
2023
Q1 | $8.03M | Sell |
524,000
-7,700
| -1% | -$118K | 0.01% | 1201 |
|
|
2022
Q4 | $7.13M | Sell |
531,700
-9,800
| -2% | -$131K | 0.01% | 1288 |
|
|
2022
Q3 | $7.2M | Sell |
541,500
-59,400
| -10% | -$1.03M | 0.01% | 1213 |
|
|
2022
Q2 | $11.5M | Buy |
600,900
+1,800
| +0.3% | +$34.1K | 0.01% | 1032 |
|
|
2022
Q1 | $12M | Sell |
599,100
-38,700
| -6% | -$781K | 0.01% | 1009 |
|
|
2021
Q4 | $13M | Buy |
637,800
+2,500
| +0.4% | +$53.4K | 0.02% | 940 |
|
|
2021
Q3 | $13.7M | Sell |
635,300
-29,900
| -4% | -$720K | 0.02% | 861 |
|
|
2021
Q2 | $19.2M | Sell |
665,200
-41,600
| -6% | -$1.13M | 0.02% | 784 |
|
|
2021
Q1 | $17.2M | Sell |
706,800
-117,200
| -14% | -$2.65M | 0.02% | 858 |
|
|
2020
Q4 | $16M | Sell |
824,000
-246,000
| -23% | -$4.52M | 0.02% | 871 |
|
|
2020
Q3 | $18.6M | Buy |
1,070,000
+135,000
| +14% | +$2.88M | 0.02% | 776 |
|
|
2020
Q2 | $24.6M | Buy |
935,000
+61,200
| +7% | +$1.52M | 0.02% | 708 |
|
|
2020
Q1 | $21.1M | Buy |
873,800
+35,300
| +4% | +$863K | 0.02% | 741 |
|
|
2019
Q4 | $20.8M | Buy |
838,500
+44,000
| +6% | +$1.02M | 0.02% | 982 |
|
|
2019
Q3 | $16.9M | Buy |
794,500
+38,000
| +5% | +$1.04M | 0.01% | 1057 |
|
|
2019
Q2 | $24M | Sell |
756,500
-22,600
| -3% | -$709K | 0.02% | 863 |
|
|
2019
Q1 | $25.7M | Sell |
779,100
-51,800
| -6% | -$1.61M | 0.02% | 839 |
|
|
2018
Q4 | $26.7M | Buy |
830,900
+27,100
| +3% | +$1.02M | 0.03% | 721 |
|
|
2018
Q3 | $34.5M | Buy |
803,800
+169,300
| +27% | +$8M | 0.04% | 622 |
|
|
2018
Q2 | $29.2M | Buy |
634,500
+97,700
| +18% | +$4.33M | 0.03% | 702 |
|
|
2018
Q1 | $21.3M | Buy |
536,800
+73,304
| +16% | +$2.71M | 0.02% | 902 |
|
|
2017
Q4 | $15.5M | Buy |
463,496
+65,396
| +16% | +$2.32M | 0.02% | 1118 |
|
|
2017
Q3 | $14.8M | Buy |
398,100
+184,316
| +86% | +$6.92M | 0.02% | 1087 |
|
|
2017
Q2 | $7.92M | Buy |
213,784
+162,384
| +316% | +$5.3M | 0.01% | 1422 |
|
|
2017
Q1 | $1.44M | Buy |
51,400
+37,500
| +270% | +$1.06M | ﹤0.01% | 2399 |
|
|
2016
Q4 | $407K | Buy |
+13,900
| New | +$379K | ﹤0.01% | 2828 |
|
|
2015
Q4 | – | Sell |
-89,600
| Closed | -$2.83M | – | 3386 |
|
|
2015
Q3 | $2.83M | Buy |
89,600
+41,800
| +87% | +$1.53M | 0.01% | 1771 |
|
|
2015
Q2 | $1.86M | Sell |
47,800
-3,900
| -8% | -$135K | ﹤0.01% | 2108 |
|
|
2015
Q1 | $1.83M | Buy |
+51,700
| New | +$1.66M | ﹤0.01% | 1979 |
|
Other funds holding PAHC
VCM
VPM
N
Renaissance Technologies's PAHC Position: Q1 2026 in Review
Renaissance Technologies increased its Phibro Animal Health (PAHC) stake by 5.8% in Q1 2026, buying an estimated $1.5M and bringing the position to 576,735 shares worth $31.9M. The position accounts for 0.05% of the portfolio, ranked #472.
Renaissance Technologies first reported a position in PAHC in Q1 2015 and has held it in 41 quarters since. The position peaked at $34.5M in Q3 2018. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.
- Renaissance Technologies held 576,735 shares of Phibro Animal Health worth $31.9M as of Q1 2026.
- Renaissance Technologies bought 31,435 Phibro Animal Health shares in Q1 2026, an estimated $1.5M.
- Phibro Animal Health made up 0.05% of Renaissance Technologies's portfolio in Q1 2026, its #472 holding.
- Renaissance Technologies first reported a position in Phibro Animal Health in Q1 2015 and has held it in 41 quarters since.
- Renaissance Technologies's Phibro Animal Health position peaked at $34.5M in Q3 2018.
- 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.